Fazili J - Search Results

1

Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis.

Madhoun MF, Fazili J, Bright BC, Bader T, Roberts DN, Bronze MS. Madhoun MF, et al. Among authors: fazili j. Am J Med Sci. 2010 Feb;339(2):169-73. doi: 10.1097/MAJ.0b013e3181c4af27. Am J Med Sci. 2010. PMID: 20087166 Review.

2

Cirrhosis and its complications: evidence based treatment.

Nusrat S, Khan MS, Fazili J, Madhoun MF. Nusrat S, et al. Among authors: fazili j. World J Gastroenterol. 2014 May 14;20(18):5442-60. doi: 10.3748/wjg.v20.i18.5442. World J Gastroenterol. 2014. PMID: 24833875 Free PMC article. Review.

3

Fluvastatin inhibits hepatitis C replication in humans.

Bader T, Fazili J, Madhoun M, Aston C, Hughes D, Rizvi S, Seres K, Hasan M. Bader T, et al. Among authors: fazili j. Am J Gastroenterol. 2008 Jun;103(6):1383-9. doi: 10.1111/j.1572-0241.2008.01876.x. Epub 2008 Apr 14. Am J Gastroenterol. 2008. PMID: 18410471 Clinical Trial.

4

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.

Sureban SM, Madhoun MF, May R, Qu D, Ali N, Fazili J, Weygant N, Chandrakesan P, Ding K, Lightfoot SA, Houchen CW. Sureban SM, et al. Among authors: fazili j. Oncotarget. 2015 Nov 10;6(35):37200-15. doi: 10.18632/oncotarget.5808. Oncotarget. 2015. PMID: 26468984 Free PMC article.

5

Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis.

Bashir MH, Fazili J, Madhoun MF, Kanagala R, Chen S, Nusrat S. Bashir MH, et al. Among authors: fazili j. Eur J Gastroenterol Hepatol. 2018 Mar;30(3):296-301. doi: 10.1097/MEG.0000000000001032. Eur J Gastroenterol Hepatol. 2018. PMID: 29200006

6

A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients.

Bader T, Hughes LD, Fazili J, Frost B, Dunnam M, Gonterman A, Madhoun M, Aston CE. Bader T, et al. Among authors: fazili j. J Viral Hepat. 2013 Sep;20(9):622-7. doi: 10.1111/jvh.12085. Epub 2013 Mar 6. J Viral Hepat. 2013. PMID: 23910646 Clinical Trial.

7

A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.

Le V, Bader T, Fazili J. Le V, et al. Among authors: fazili j. Nat Clin Pract Gastroenterol Hepatol. 2009 Jan;6(1):57-60. doi: 10.1038/ncpgasthep1317. Epub 2008 Nov 25. Nat Clin Pract Gastroenterol Hepatol. 2009. PMID: 19029995

8

Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.

Ali N, Nguyen CB, Chandrakesan P, Wolf RF, Qu D, May R, Goretsky T, Fazili J, Barrett TA, Li M, Huycke MM, Bronze MS, Houchen CW. Ali N, et al. Among authors: fazili j. Sci Rep. 2020 Jun 29;10(1):10578. doi: 10.1038/s41598-020-67401-y. Sci Rep. 2020. PMID: 32601309 Free PMC article.

9

Outcome of a hepatitis C outbreak among patients in a pain management clinic.

Fazili J, Mallonee S, Tierney WM, Bader TF, Sachdev AK, Bird PC, Schmidt RD, Mesiya SA, Lackey CL. Fazili J, et al. Dig Dis Sci. 2010 Jun;55(6):1738-43. doi: 10.1007/s10620-010-1228-z. Epub 2010 Apr 22. Dig Dis Sci. 2010. PMID: 20411419

10

Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals.

Syed T, Fazili J Dr, Ali IA, Zhao D, Hughes D, Mahmood S MD. Syed T, et al. Among authors: fazili j dr. Cureus. 2018 Jun 19;10(6):e2843. doi: 10.7759/cureus.2843. Cureus. 2018. PMID: 30280052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters